Last reviewed · How we verify
NCT06114303: EPROMED
Ex-vivo Evaluation of the Effect of 2 Probiotic Solutions (Lactibiane ATB and Lactibiane Enfant) and 5 Classes of Drugs on the Intestinal Microbiota
trial testing Stool sampling in Dysbiosis in 14 participants. Terminated before completion.
16 June 2025
Quick facts
| Lead sponsor | Larena SAS |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 14 |
| Start date | 14 March 2024 |
| Primary completion | 16 June 2025 |
| Estimated completion | 16 June 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- Stool sampling — full drug profile →
Conditions studied
- Dysbiosis — all drugs for Dysbiosis →
Sponsor
Larena SAS
Who can join
Adults 1 to 40, female only, with Dysbiosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective is to test ex-vivo the effects of two probiotic solutions (Lactibiane ATB and Lactibiane Enfant) and five classes of drugs (antibiotic, proton pump inhibitor, non-steroidal anti-inflammatory, anxiolytic and anti-depressant) on microbial microcosms derived from human stool samples (from adults and children) re-cultured under anaerobic conditions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06114303
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Stool sampling
Trials testing the same drug.
- NCT05319067 — Study of Gut Microbiota Diversity in Children Aged 1-3 Years on Prolonged Antibiotic Prophylaxis for Grade 3 or Higher V · recruiting
- NCT05213910 — Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of · NA · completed
- NCT03032640 — Interactions of Human Gut Microbiota With Intestinal Sweet Taste Receptors · NA · completed
Other recruiting trials for Dysbiosis
Currently open trials in the same condition.
- NCT07148583 — BioAmicus Complete for Functional Gastrointestinal Symptoms in Infants Aged 0 to 24 Months · NA · recruiting
- NCT07231003 — The Effect of Glucomannan Powder on Improving Gut Microbiota. · NA · active not recruiting
- NCT06877585 — Association Between Fecal Microbiota Composition, Metabolite Concentrations, and Indoxyl Sulfate Levels · recruiting
- NCT06872320 — The Influence of Probiotics on Metabolome and Heart Rate Variability in Heart Failure of Structure Heart Disease · NA · active not recruiting
- NCT06914375 — Effect of Lentils and Chickpeas on Gut Microbiome and Metabolic Health · NA · active not recruiting
Other Larena SAS trials
Trials by the same sponsor.
- NCT06137898 — The Benefits of Dietary and Micro-nutritional Management for Well-being at Work · unknown
- NCT05830565 — Management of Occasional or Anticipatory Stress by Consumers of a Food Supplement · completed
- NCT05419466 — Kinetic of Compounds of a Melatonin-based Formulation in Healthy Subjects · NA · completed
- NCT05199545 — Efficacy Study in Phytotherapy of an Association of Plants in the Improvement of Psychological Well-being · NA · completed
- NCT05159271 — Efficacy and Safety of Azeol Nasal Spray Versus Placebo in the Treatment of Early Symptoms of Common Cold in Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06114303 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Larena SAS
- Last refreshed: 2 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06114303.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing